NCT06691984: Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
- State
- Under way
- Phase
- Phase 3
- People
- 707 taking part
- Started
- 9 Dec 2024
- Primary completion
- 2 Jan 2029
- Arms
- Xaluritamig
- Results
- None posted
- 18 Nov 2024: Trial registered
- 9 Dec 2024: Trial started